Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

HIV patients with lower CD4 T cell counts often have more skin problems.

PRP and cell therapies may help with hair loss, but more research is needed.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.